SCHEMBL76731

SCHEMBL76731

O=[C]C=Cc1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 4/20 0.52
TYR P14679 4/20 0.52
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
CYP2C9 P11712 3/20 0.52
CYP2D6 P10635 2/20 0.52
F3 P13726 2/20 0.52
HSD11B1 P28845 1/20 0.52
CA12 O43570 6/20 0.50
CA1 P00915 6/20 0.50
CA7 P43166 6/20 0.50
CA9 Q16790 6/20 0.50
CA14 Q9ULX7 6/20 0.50
CA2 P00918 5/20 0.50
CA4 P22748 4/20 0.50
CA6 P23280 4/20 0.50
CA5A P35218 4/20 0.50
CA5B Q9Y2D0 4/20 0.50
AKR1B1 P15121 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2821449 1.00 APP (0.52) APPTYRKDM4EALDH1A1MAPT
SCHEMBL196959 1.00 APP (0.52) APPTYRKDM4EALDH1A1MAPT
SCHEMBL3715296 0.78 CYP2A6 (0.44) TYRKDM4EALDH1A1KMT2AHSD17B10
SCHEMBL3715295 0.78 CYP2A6 (0.44) TYRKDM4EALDH1A1KMT2AHSD17B10
SCHEMBL2339964 0.76 CYP2C19 (0.42) KDM4EALDH1A1MAPTCYP2C9CYP2D6
SCHEMBL2342481 0.76 CYP1A2 (0.50) ALDH1A1MAPTMAOBPTGS2LMNA
SCHEMBL5332130 0.76 ESR1 (0.57) APPTYRKDM4EALDH1A1MAPT
SCHEMBL11042248 0.76 APP (0.43) APPKDM4ECA1CA2ABL1
SCHEMBL3051230 0.76 APP (0.52) APPALDH1A1MAPTMAOBMEN1
SCHEMBL11042246 0.76 APP (0.43) APPKDM4ECA1CA2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 954 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271331-A Gelsemin derivatives, synthesis method and application thereof in inhibiting tumor cell proliferation 赣江中药创新中心 2024-07-02 CN claimed
WO-2024110539-A1 ENHANCED PRODUCTION OF FLAVONOIDS QINGDAO INST BIOENERGY & BIOPROCESS TECH CAS (CN) 2024-05-30 WO claimed
CN-113774159-B Tea tree 4-coumaroyl CoA ligase gene SSR molecular marker primer and application 广西壮族自治区亚热带作物研究所(广西亚热带农产品加工研究所) 2024-03-08 CN claimed
EP-4323528-A1 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. (US) 2024-02-21 EP claimed
US-11898183-B2 Programmed microorganisms to attenuate a disease MURALI PANCHAPAGESA MUTHUSWAMY (IN) 2024-02-13 US claimed
WO-2023094774-A1 METHOD FOR THE BIOSYNTHESIS OF CAFFEIC ACID AND FERULIC ACID ABOLIS BIOTECHNOLOGIES (FR) 2023-06-01 WO claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
WO-2023275142-A1 FRAGRANCED COSMETIC COMPOSITION COMPRISING AT LEAST ONE ORGANIC ACID ESTER, AN ANTHOCYANI(DI)N DYE AND A FRAGRANCING MATERIAL L'OREAL (FR) 2023-01-05 WO claimed
CN-115364077-A Lonicera edulis xanthophyll preparation, eye drops and application of eye drops in relieving asthenopia 浙江双糖生物科技有限公司 2022-11-22 CN claimed
WO-2022221392-A1 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. (US) 2022-10-20 WO claimed
US-5863748-A p-Hydroxycinnamoyl-containing substrates for an analyte dependent enzyme activation system NEW LIFE SCIENCE PRODUCTS, INC. (US) 1999-01-26 US claimed
WO-1998008868-A9 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS 1998-05-28 WO claimed
WO-1998008868-A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS PRAECIS PHARMACEUTICALS INCORPORATED (US) 1998-03-05 WO claimed
WO-1997035999-A2 PRODUCTION OF VANILLIN INSTITUTE OF FOOD RESEARCH (GB) 1997-10-02 WO claimed
EP-0463945-B1 Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1995-12-27 EP claimed
EP-0463945-A1 Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1992-01-02 EP claimed
EP-0074505-B1 FERTILITY INDICATOR SYSTEM Goldman, Dorothee, F.E. (US) 1986-11-12 EP claimed
WO-1983001117-A1 FERTILITY INDICATOR SYSTEM CONTAINING ANTHOCYANIN PIGMENT GOLDMAN, DOROTHEE, F., E. 1983-03-31 WO claimed
EP-0074505-A2 Fertility indicator system Goldman, Dorothee, F.E. (US) 1983-03-23 EP claimed
US-4358288-A Fertility indicator system containing anthocyanin pigment GOLDMAN, DOROTHEE F.E. 1982-11-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES FABP2, FABP4, GUSB APP 1117/4885TYR 2156/4885KDM4E 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.